ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

A Shift in Paradigm: Phosphatidylethanol Testing to Monitor for and Address Alcohol Recidivism Following Liver Transplantation

F. M. Nimri1, S. Naffouj1, F. Askar1, A. Singh2, H. Gonzalez2, S. Jafri2

1Internal Medicine, Henry Ford Hospital, Detroit, MI, 2Gastroenterology, Henry Ford Hospital, Detroit, MI

Meeting: 2021 American Transplant Congress

Abstract number: 1107

Keywords: Alcohol, Liver cirrhosis, Liver failure, Liver transplantation

Topic: Clinical Science » Liver » Liver: Recipient Selection

Session Information

Session Name: Liver: Recipient Selection

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: Phosphatidylethanol (PEth) is a phospholipid that forms in the presence of ethanol with a long half-life compared to other alcohol detection tests. PEth testing is highly sensitive and specific and has become an important factor in the process of pre-transplant evaluation as well as post-transplant follow-up. We evaluated the role of PEth in identifying recidivism and the impact of psychological intervention in identified patients.

*Methods: We performed a retrospective study at a large tertiary care center of all patients who had alcohol recidivism after liver transplant demonstrated by a positive PEth test between 1/2018 and 1/2020. PEth test was considered positive if level was > 20 ng/dl. Intervention by psychologic counseling and relapse prevention was offered and patients were followed to assess if they were able to abstain from alcohol following intervention.

*Results: A total of 20 patients (mean age 53.35 ± 8.97 years) were identified. All patients were white, and 14 (70%) were males. 17 patients (85%) had prior known alcoholic liver disease, 1 had nonalcoholic steatohepatitis (NASH), and 2 patients had cryptogenic liver disease. 19 patients had liver cirrhosis prior to transplant, and one had acute alcoholic hepatitis. 4 of the patients had pre-transplant PEth test and they were all negative. Mean PEth level post-transplant was 406 ng/ml. 11 patients agreed to undergo a psychological intervention to aid in alcohol cessation including relapse prevention (7/11), Alcoholic Anonymous (AA, 2/11), inpatient rehab + AA sessions (1/11), and relapse prevention + AA (1/11). 8 out of the 11 patients undergoing intervention reported abstinence on subsequent visits, however a follow-up PEth test was positive in 2 patients out of those 8 patients. 9 patients did not receive any intervention and continued to drink. 3 out of 9 had PEth test and it was positive (mean PEth level 297 ng/ml). 5 out 20 patients had graft rejection and only 1 of those 5 underwent a psychosocial intervention and stopped drinking. 2 patients died; both continued to drink post-transplant. One died of acute alcoholic hepatitis and was from the no intervention group, while the other underwent an intervention but nonetheless continued to drink and died due to a falling accident.

*Conclusions: PEth test has been largely implemented in the process of liver transplant evaluation and post-transplant follow-up to ensure abstinence and compliance with the transplant requirements. It has recently played a role in pre-transplant evaluation. In this study, we found that PEth testing identified patients who had recidivism and those who continued to use alcohol despite undergoing relapse prevention. Larger studies are needed to accurately evaluate the benefit of broader PEth testing in post-liver transplant follow-up.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Nimri FM, Naffouj S, Askar F, Singh A, Gonzalez H, Jafri S. A Shift in Paradigm: Phosphatidylethanol Testing to Monitor for and Address Alcohol Recidivism Following Liver Transplantation [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/a-shift-in-paradigm-phosphatidylethanol-testing-to-monitor-for-and-address-alcohol-recidivism-following-liver-transplantation/. Accessed May 11, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences